Patent: 10,011,635
✉ Email this page to a colleague
Summary for Patent: 10,011,635
Title: | Cyclic peptide conjugates and methods of use |
Abstract: | The present invention concerns cyclic compounds, compositions comprising the cyclic compounds, linkers, a method of preparing a carrying agent:cyclic compound adduct, a method for treating disorders such as proliferation disorders (e.g., malignancies), bone deficiency diseases, and autoimmune diseases, and a method for suppressing the growth of, or inducing apoptosis in, cells (e.g., malignant cells). |
Inventor(s): | Hazlehurst; Lori (Morgantown, WV), Rader; Christoph (Jupiter, FL), Li; Xiuling (Jupiter, FL), McLaughlin; Mark (Tampa, FL) |
Assignee: | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (Tampa, FL) UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) MODULATION THERAPEUTICS (Tampa, FL) THE SCRIPPS RESEARCH INSTITUTE (La Jolla, CA) |
Application Number: | 15/024,928 |
Patent Claims: | see list of patent claims |
Details for Patent 10,011,635
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2033-09-27 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2033-09-27 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2033-09-27 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |